Data / Form D filings / PIPr Therapeutics, Inc.
PIPr Therapeutics, Inc.: Form D filings
PIPr Therapeutics, Inc., a biotechnology company in Durham, NC, filed 6 Form D notices with the SEC between 2016 and 2025. The latest, on November 12, 2025, reports $1.5 million sold of a $2.5 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 280 S. MANGUM ST., SUITE 350, Durham, NC, 27701
- Phone
- (919) 357-8326
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1687466
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | New notice | $2,499,992 | $1,499,995 | $999,997 | 3 | Oct 31, 2025 | sec.gov |
| Jun 15, 2022 | Amendment | $18,877,921 | $18,877,921 | 7 | Dec 21, 2020 | sec.gov | |
| Dec 23, 2020 | New notice | $10,877,922 | $10,877,922 | 6 | Dec 21, 2020 | sec.gov | |
| Mar 4, 2020 | New notice | $2,000,000 | $1,738,391 | $261,609 | 4 | Feb 28, 2020 | sec.gov |
| Mar 8, 2019 | New notice | $5,000,000 | $5,000,000 | 6 | Mar 4, 2019 | sec.gov | |
| Oct 14, 2016 | New notice | $5,000,000 | $3,000,000 | $2,000,000 | 5 | Sep 29, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Clay Thorp | Director | |
| Holden Thorp | Director | |
| Heather Madsen | Executive Officer, Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Nov 10, 2025 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PIPr Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.